Catalyst Wire Dossier Catalyst Wire Dossier

NINLARO

ixazomib · Takeda Pharmaceuticals America, Inc.
Drug timelines are a Plus or Pro feature.

45 regulatory and trial events tracked for NINLARO, covering 2015-11-20 to 2026-08-05. Get the full timeline:

Most recent: EMA Authorised: Ninlaro (ixazomib citrate) — Takeda Pharma A/S

See pricing